Skip to main content

Advertisement

Log in

Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

In order to update the epidemiological and mycological profile of candidaemia in Europe, the European Confederation of Medical Mycology conducted a prospective, sequential, hospital population-based study from September 1997 to December 1999. A total of 2,089 cases were documented by 106 institutions in seven European countries. Rates of candidaemia ranging from 0.20 to 0.38 per 1,000 admissions were reported. Candida albicans was identified in 56% of cases. Non-albicans Candida species were most frequently isolated from patients with haematological malignancies (65%). With increasing age, an increasing incidence of Candida glabrata was seen. The 30-day mortality rate was 37.9%. The survey results underline the burden of candidaemia in a wide range of patient populations, confirm the importance of non-albicans species, and provide baseline data for future surveillance studies at a European level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jarvis WR (1995) Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20:1526–1530

    CAS  PubMed  Google Scholar 

  2. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN,Wenzel RP (1999) Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29:239–244

    CAS  PubMed  Google Scholar 

  3. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1988) Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 148:2642–2645

    CAS  PubMed  Google Scholar 

  4. Wenzel RP, Edmond MB (2001) The impact of hospital acquired bloodstream infections. Emerg Infect Dis 7:174–177

    CAS  PubMed  Google Scholar 

  5. Pelz RK, Lipsett PA, Swoboda SM, Diener-West M, Powe NR, Brower RG, Perl TM, Hammond JM, Hendrix CW (2000) Candida infections: outcome and attributable ICU costs in critically ill patients. J Intens Care Med 15:255–261

    Article  Google Scholar 

  6. Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins A, Stephens DS, Baughman WS, Reingold AL, Rothrock GA, Pfaller MA, Pinner RW, Hajjeh RA (1999) The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 29:1164–1170

    CAS  PubMed  Google Scholar 

  7. Sandven P (2000) Epidemiology of candidemia. Rev Iberoam Micol 17:73–81

    Google Scholar 

  8. Pfaller MA, Diekema DJ (2002) Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol 40:3551–3557

    Article  CAS  PubMed  Google Scholar 

  9. Launay O, Lortholary O, Bouges-Michel C, Jarrousse B, Bentata M, Guillevin L (1998) Candidemia: a nosocomial complication in adults with late-stage AIDS. Clin Infect Dis 26:1134–1141

    CAS  PubMed  Google Scholar 

  10. Tumbarello M, Tacconelli E, De Gaetano Donati K, Morace G, Fadda G, Cauda R (1999) Candidemia in HIV-infected subjects. Eur J Clin Microbiol lnfect Dis 18:478–483

    Article  CAS  Google Scholar 

  11. Viscoli C, Girmenia C, Marinus A, Collette L, Martino P, Vandercam B, Doyen C, Lebau B, Spence D, Krcmery V, De Pauw B, Meunier F (1999) Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin lnfect Dis 28:1071–1079

    CAS  Google Scholar 

  12. Richet H, Roux P, Des Champs C, Esnault Y, Andremont A; French candidemia study group (2002) Candidemia in French hospitals: incidence rates and characteristics. Clin Microbiol Infect 8:405–412

    Article  CAS  PubMed  Google Scholar 

  13. Grillot R (1997) Epidemiological survey of candidemia in Europe. ECMM Mycology Newsletter 0/97:12–14

  14. Donelly SM, Sullivan DJ, Shanley DB, Coleman DC (1999) Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 145:1871–1882

    CAS  PubMed  Google Scholar 

  15. Marot-Leblond A, Grimaud L, Nail S, Bouterige S, Apaire-Marchais V, Sullivan DJ, Robert R (2000) New monoclonal antibody specific for Candida albicans germ tube. J Clin Microbiol 38:61–67

    CAS  PubMed  Google Scholar 

  16. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meiss JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ (2002) Defining oportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic cell transplants: an international consensus. Clin Infect Dis 34:7–14

    CAS  PubMed  Google Scholar 

  17. Bernhardt H, Zimmermann K, Sissolak D, Schutt-Gerwitt H, Schroder G, Enzensberger R, Willinger B, Weig M, Berns G, Grisold A, Seewald M, Ziegler E, Ruchel R, Burkhardt S, Sommer B, Graf B, Jahn B, Asboth F, Meyer L (2000) Epidemiological survey on candidemia in Europe: results of Germany and Austria. Rev Iberoam Micol 17 (Suppl 3):146–147

    Google Scholar 

  18. Grillot R, Faure O, Fruit J, Sendid B, Rispail P, Datry A, Biava MF, Kures L, Morin O, Toubas D, Bretagne S, Bouteille B, Lebau B, Cassaing S, Cuisenier B, Grawey I, Poirot JL, Eloy O, Kauffmann-Lacrooix C, de Champs C, Kac G, Lavarde V, Baixench M, Bougnoux ME, Lachaud L, Lamy C, Pellet E, Biondi C (2000) ECMM prospective epidemiological survey of candidemia in Europe: report from France. Rev Iberoam Micol 17 (Suppl 3):144

  19. Klingspor L, Tornquist E, Johansson A, Petrini B, Forsum U, Hedin G (2000) ECMM’s survey of candidemia in Europe: report from Sweden. Rev Iberoam Micol 17 (Suppl 3):147

    Google Scholar 

  20. Pemán J, Cantón E, Orero A, Viudes A, Frasquet J, Gobernado M (2002) Estudio multicentrico sobre la epidemiologia de las candidemias en Espana. Rev Iberoam Micol 19:30–35

    PubMed  Google Scholar 

  21. Tortorano AM, Biraghi E, Astolfi A, Ossi C, Tejada M, Farina C, Perin S, Bonaccorso C, Cavanna C, Raballo A, Grossi A, the FIMUA candidemia study group (2002) European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. J Hosp Infect 51:297–304

    Article  CAS  PubMed  Google Scholar 

  22. Kibbler CC, Seaton S, Barnes RA, Gransden WR, Holliman RE, Johnson EM, Perry JD, Sullivan DJ, Wilson JA (2003) Manangement and outcome of bloostream infections due to Candida species in England and Wales. J Hosp Infect 54:18–24

    Article  CAS  PubMed  Google Scholar 

  23. Tortorano AM, Peman J, Faure O, Bernhardt H, Kibbler CC, Grillot R (2001). Bloodstream infections due to Candida species in AIDS patients: report of 63 episodes from the European Confederation of Medical Mycology (ECMM). Clin Infect Dis 33:1219

    Google Scholar 

  24. Tortorano AM, Peman J, Klingspor L, Bernhardt H, Kibbler C, Faure O, Biraghi E, Canton E, Zimmmermann K, Ainscough S, Grillot R (2001) Candidaemia in premature neonates. Report of 123 episodes from the ECMM working group. Mycoses 44 (Suppl 1):76

  25. Nucci M, Colombo AL, Silveira F, Richtmann R, Salomao R, Branchini ML, Spector N (1998) Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol 19:846–850

    CAS  PubMed  Google Scholar 

  26. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, Wenzel RP and the NEMIS Study Group (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis 33:177–186

    CAS  PubMed  Google Scholar 

  27. Nucci M, Anaissie E (2001) Revisiting the source of candidemia: skin or gut? Clin Infect Dis 33:1959–1967

    Article  CAS  PubMed  Google Scholar 

  28. Wingard JR (1995) Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 20:115–125

    CAS  PubMed  Google Scholar 

  29. Wingard JR, Dick JD, Merz WG, Sandford GR, Saral R, Burns WH (1982) Differences in virulence of clinical isolates of Candida tropicalis and Candida albicans in mice. Infect Immun 37:833–836

    CAS  PubMed  Google Scholar 

  30. Oude Lashof AML, Donelly JP, Meis JFGM, Meer JWM, Kullberg BJ (2003) Duration of antifungal treatment and development of delayed complications in patients with candidaemia. Eur J Clin Microbol Infect Dis 22:43–48

    Google Scholar 

  31. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE (2000) Practice guidelines for the treatment of candidiasis. Clin Infect Dis 30:662–678

    CAS  PubMed  Google Scholar 

  32. Walsh TJ, Rex JH (2002) All catheter-related candidemia is not the same: assessment of the balance between the risks and benefits of removal of vascular catheters. Clin Infect Dis 34:600–602

    PubMed  Google Scholar 

  33. Wold Health Organisation (2003) Atlas of health in Europe. WHO Regional Office for Europe, Copenhagen, Denmark

Download references

Acknowledgments

The ECMM Working Group consists of the following members:

France: M.-F. Biava, L. Kures, CHU Nancy; M.-E. Bougnoux, CHU Ambroise-Paré, Paris; B. Bouteille, CHU Limoges; S. Bretagne, CHU Henri Mondor, Paris Créteil; B. Cuisenier, CHU Dijon; A. Datry, CHU Pitié-Salpétrière, Paris; C. De Champs, M. Cambon, CHU Clermont-Ferrand; C. Duhamel, CHU Caen; J. Dupouy-Camet, CHU Cochin, Paris; J.-P. Gangneux, CHU Rennes; C. Kauffmann-Lacroix, CHU Poitiers; O. Eloy, CHR Versailles; J. Fruit, B. Sendid, CHU Lille; I. Grawey, CHR Colmar; G. Kac, CHU Tenon, Paris; L. Lachaud, CHU Nîmes; V. Lavarde, CHU Broussais, Paris; B. Lebeau, CHU Grenoble; M.-D. Linas, CHU Rangueuil, Toulouse; O. Morin, CHU Nantes; G. Nevez, CHU Amiens; J.-L. Poirot, CHU Saint-Antoine; H. Raberin, CHU Saint-Etienne, Paris; P. Rispail, CHU Montpellier, Paris; D. Toubas-Puygauthier, CHU Reims, Paris.

Austria: D. Sissolak, Dept. Clin. Microbiology, Vienna; B. Willinger, Dept. Clin. Microbiology, Vienna; A. Grisold, Inst. Hygiene-Microbiology, Graz; F. Asboth, Path-Bact. Institute, Vienna.

Germany: H. Schütt-Gerowitt, Inst. Med. Microbiology, Köln; G. Schröder, Inst. Med. Microbiology, Greifswald; R. Enzensberger, Dept. Clin. Microbiology, Frankfurt a. M; L. Leitritz, Max v. Pettenkofer-Institute, Munich; M. Weig, Inst. Hygiene-Microbiology, Würzburg; G. Berns, Inst. Med. Microbiology, Dusseldorf; M. Seewald, Inst. Med. Diagnostic, Berlin; E. Ziegler, Inst. Pathology Barmherzigen Schwestern v. Hl. Kreuz, Wels; R. Rüchel, Inst. Hygiene, Göttingen; S. Burkhardt, Inst. Med. Microbiology, Munich; B. Sommer, Community Lab. Medicine, Potsdam; B. Graf, Inst. Microbiology-Hygiene (Charité), Berlin; B. Jahn, Inst. Microbiology- Hygiene, Mainz; L. Meyer, Children’s Clinic, Mainz.

Italy: C. Agrappi, Ospedale, Legnano; M. Arghittu, Ospedale Predabissi, Melegnano; A. Astolfi, Ospedale Niguarda Ca’ Granda, Milan; C. Bezzi, Ospedale, Magenta; C. Bonaccorso, Ospedale Sacco, Milan; S. Bramati, Ospedale S. Gerardo, Monza; P. Casella, Ospedale, Vimercate; C. Cavanna, IRCCS Ospedale San Matteo, Pavia; A. Ceraminiello, Ospedale, Lodi; L. Colombo, Ospedale, Desio; C. Farina, Ospedali Riuniti, Bergamo; L. Ferrari, Istituti Ospedalieri, Cremona; S. Frugoni, Pio Albergo Triulzio, Milan; L. Garlaschi, Istituti Clinici di Perfezionamento, Milan; G. Gialluca, Ospedale, Rho; A. Grossi, Ospedale, Treviglio; S. Gualterotti, Ospedale Bassini, Cinisello Balsamo; G. Lombardi, Ospedale Circolo, Varese; A. Mauri, Ospedale S. Paolo, Milan; M.G. Musmanno, Ospedale, Saronno; C. Ossi, IRCCS Ospedale San Raffaele, Milan; R. Passerini, Istituto Europeo Oncologia, Milan; S. Perin, Ospedale S. Carlo, Milan; S. Pierdomenico, Ospedale, Busto Arsizio; G. Pinsi, Spedali Civili, Brescia; P. Porri, Ospedale, Voghera; A. Raballo, Ospedale Poma, Mantova; A. Rigoni, IRCCS Ospedale Maggiore, Milan; R. Sala, Ospedale, Merate; M. Saudelli, Ospedale Fatebenefratelli, Milan; M. Spinelli, Ospedale S. Anna, Como; C. Sturla, Ospedale S. Antonio, Gallarate; M. Tejada, Istituto Policlinico S. Donato, S. Donato Milanese; P. Troupioti, Ospedale, Sondalo; G. Viola, Istituto Nazionale Tumori, Milan; A. Lizioli, L. Merlino, Regione Lombardia, Direzione Generale Sanità.

Spain: A. Viudes, H. LaFe, Valencia; A. Planes, H. Vall dHebrón, Barcelona; E. Cañas, H. Virgen Rocío, Seville; A. del Palacio, H. 12deOctubre, Madrid; J. Sevillano, C M Povisa, Vigo; J. Viñuelas, H. S Pedro de Alcántara, Cáceres; M. Elía, H. U., Elche; M. Giménez, H. Germans, Trías i Pujol; M. Pazo, H. Carlos Haya, Málaga; J.J. García, H. de Navarra, Pamplona; J.J. Palomar, H. General, Albacete; J.M. Hernández-Molina, H. La Inmaculada, Huercal-Overa; E. Mínguez, H. Canalejo, A Coruña; J.A. Martínez, H. Clinic, Barcelona; I. Fernández, H. de León, León; J. Martínez, H. Virgen de la Salud, Toledo; M.J. Tapiol, H. Joan XXIII, Tarragona; M.S. Cuétara, H. Severo Ochoa, Leganés; S. Giner, H. Dr Moliner, Bétera.

Sweden: E. Törnquist, Örebro Medical Center Hospital, Örebro; B. Petrini, Karolinska Hospital, Stockholm; U. Forsum, Linköping University Hospital, Linköping; G. Hedin, Central Hospital, Västerås.

UK: R.A. Barnes, University of Wales College of Medicine, Cardiff; W.R. Gransden, Guys and St Thomas’s Hospital, London; R.E. Holliman, St Georges Hospital, London; J.D. Perry, Freeman Hospital, Newcastle Upon Tyne; J.A. Wilson, Hull PHLS, Hull.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to A. M. Tortorano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tortorano, A.M., Peman, J., Bernhardt, H. et al. Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study. Eur J Clin Microbiol Infect Dis 23, 317–322 (2004). https://doi.org/10.1007/s10096-004-1103-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-004-1103-y

Keywords

Navigation